Daniel M. Hancock - 05 Jun 2026 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Reporting relationship: Director
Issuer ticker: CYRX
Reported as of: 05 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 21:09:51 UTC
Prior SEC filing: 10 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Daniel M. Hancock

Key filing fact

Daniel M. Hancock filed Form 4 for Cryoport, Inc. (CYRX) on 08 Jun 2026.

Key facts

This page summarizes Daniel M. Hancock's Form 4 filing for Cryoport, Inc. (CYRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2026, 21:09.

Change

Previous filing in this sequence was filed on 10 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001764017 Primary reporting owner

HANCOCK DANIEL M

Relationship: Director
Address: C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
Signature: /s/ Daniel M. Hancock
Signature date: 08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYRX transaction

Common Stock

Award

Transaction value
Shares: +10,350
Change %: +18%
Price: $0.000000^*
Shares after: 69,052
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYRX transaction Derivative

Option (Right to Buy Common Stock)

Award

Transaction value
Shares: +16,077
Change %
Price: $0.000000^*
Shares after: 16,077
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,077
Exercise price: $15.70
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

Footnote F2

1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.